Fraxiparine (Nadroparin Calcium)

Fraxiparine is a medication containing Nadroparin Calcium, used for anticoagulation. It is suitable for subcutaneous or intravenous administration, including during haemodialysis.

Fraxiparine is primarily used to prevent and treat blood clots. It is often administered to patients undergoing haemodialysis to maintain the patency of the dialysis circuit. This medication is also used for subcutaneous injection to prevent deep vein thrombosis and pulmonary embolism in certain high-risk individuals.

Common effects of Fraxiparine may include bruising, bleeding, and pain at the injection site. Some users may experience allergic reactions or unusual bleeding. It is important to monitor for signs of bleeding, such as prolonged nosebleeds or unusual bruising.

Fraxiparine should be used with caution in patients with a history of bleeding disorders or recent surgery. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking.

Fraxiparine may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare professional before combining Fraxiparine with other medications.